Zhongpeng Lu

633 total citations
17 papers, 418 citations indexed

About

Zhongpeng Lu is a scholar working on Molecular Biology, Hepatology and Pathology and Forensic Medicine. According to data from OpenAlex, Zhongpeng Lu has authored 17 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Hepatology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Zhongpeng Lu's work include Liver physiology and pathology (6 papers), Cancer Mechanisms and Therapy (5 papers) and Melanoma and MAPK Pathways (4 papers). Zhongpeng Lu is often cited by papers focused on Liver physiology and pathology (6 papers), Cancer Mechanisms and Therapy (5 papers) and Melanoma and MAPK Pathways (4 papers). Zhongpeng Lu collaborates with scholars based in China, United States and Singapore. Zhongpeng Lu's co-authors include Xing Lin, Quanfang Huang, Jinbin Wei, Facheng Bai, Renbin Huang, Karen L. Abbott, Shujuan Lv, Blake Johnson, Quanfang Huang and Shijun Zhang and has published in prestigious journals such as Journal of Biological Chemistry, Scientific Reports and Journal of Ethnopharmacology.

In The Last Decade

Zhongpeng Lu

17 papers receiving 416 citations

Peers

Zhongpeng Lu
Yong‐Zhan Zhen China
Fangfang Li China
Hui Chai China
Xiufeng Ye China
Asmaa Oun Netherlands
Ayman A. Soubh Egypt
Min Sung Joo South Korea
Xia Yang China
Zhuowei Gao China
Yong‐Zhan Zhen China
Zhongpeng Lu
Citations per year, relative to Zhongpeng Lu Zhongpeng Lu (= 1×) peers Yong‐Zhan Zhen

Countries citing papers authored by Zhongpeng Lu

Since Specialization
Citations

This map shows the geographic impact of Zhongpeng Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhongpeng Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhongpeng Lu more than expected).

Fields of papers citing papers by Zhongpeng Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhongpeng Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhongpeng Lu. The network helps show where Zhongpeng Lu may publish in the future.

Co-authorship network of co-authors of Zhongpeng Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhongpeng Lu. A scholar is included among the top collaborators of Zhongpeng Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhongpeng Lu. Zhongpeng Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Johnson, Blake, Zhongpeng Lu, Leslie K. Climer, et al.. (2020). Novel role for the Golgi membrane protein TMEM165 in control of migration and invasion for breast carcinoma. Oncotarget. 11(28). 2747–2762. 15 indexed citations
2.
Lu, Zhongpeng, et al.. (2019). Generation of a Fully Human scFv that binds Tumor-Specific Glycoforms. Scientific Reports. 9(1). 5101–5101. 16 indexed citations
3.
Huang, Quanfang, Xiaolin Zhang, Facheng Bai, et al.. (2018). Methyl helicterte ameliorates liver fibrosis by regulating miR-21-mediated ERK and TGF-β1/Smads pathways. International Immunopharmacology. 66. 41–51. 23 indexed citations
4.
Lin, Xing, Jinbin Wei, Facheng Bai, et al.. (2018). Inhibition of RKIP aggravates thioacetamide‑induced acute liver failure in mice. Experimental and Therapeutic Medicine. 9 indexed citations
5.
6.
Johnson, Blake, et al.. (2017). The glycosyltransferase GnT-III activates Notch signaling and drives stem cell expansion to promote the growth and invasion of ovarian cancer. Journal of Biological Chemistry. 292(39). 16351–16359. 39 indexed citations
7.
Bai, Facheng, Quanfang Huang, Jinbin Wei, et al.. (2017). Gypsophila elegans isoorientin-2″-O-α-l-arabinopyranosyl ameliorates porcine serum-induced immune liver fibrosis by inhibiting NF-κB signaling pathway and suppressing HSC activation. International Immunopharmacology. 54. 60–67. 22 indexed citations
8.
Bai, Facheng, Quanfang Huang, Chunyuan Lu, et al.. (2017). Trolline Ameliorates Liver Fibrosis by Inhibiting the NF-κB Pathway, Promoting HSC Apoptosis and Suppressing Autophagy. Cellular Physiology and Biochemistry. 44(2). 436–446. 42 indexed citations
9.
Wei, Jinbin, Quanfang Huang, Facheng Bai, et al.. (2016). Didymin induces apoptosis through mitochondrial dysfunction and up-regulation of RKIP in human hepatoma cells. Chemico-Biological Interactions. 261. 118–126. 23 indexed citations
10.
Huang, Quanfang, Ling Wei, Chunyuan Lu, et al.. (2016). Loss of Raf kinase inhibitor protein is associated with malignant progression in hepatic fibrosis. Biomedicine & Pharmacotherapy. 82. 669–676. 6 indexed citations
11.
Lin, Xing, Jinbin Wei, Yongxin Chen, et al.. (2016). Isoorientin from Gypsophila elegans induces apoptosis in liver cancer cells via mitochondrial-mediated pathway. Journal of Ethnopharmacology. 187. 187–194. 54 indexed citations
12.
Lin, Xing, et al.. (2016). Didymin Alleviates Hepatic Fibrosis Through Inhibiting ERK and PI3K/Akt Pathways via Regulation of Raf Kinase Inhibitor Protein. Cellular Physiology and Biochemistry. 40(6). 1422–1432. 50 indexed citations
13.
Huang, Quanfang, Ling Wei, Chunyuan Lu, et al.. (2016). Raf Kinase Inhibitory Protein Down-Expression Exacerbates Hepatic Fibrosis In Vivo and In Vitro. Cellular Physiology and Biochemistry. 40(1-2). 49–61. 10 indexed citations
14.
Wei, Ling, Shujuan Lv, Quanfang Huang, et al.. (2015). Pratensein attenuates Aβ-induced cognitive deficits in rats: Enhancement of synaptic plasticity and cholinergic function. Fitoterapia. 101. 208–217. 34 indexed citations
15.
Huang, Quanfang, et al.. (2015). Pratensein ameliorates β-amyloid-induced cognitive impairment in rats via reducing oxidative damage and restoring synapse and BDNF levels. Neuroscience Letters. 592. 48–53. 23 indexed citations
16.
Lin, Xing, Shijun Zhang, Renbin Huang, et al.. (2014). Protective effect of madecassoside against cognitive impairment induced by d-galactose in mice. Pharmacology Biochemistry and Behavior. 124. 434–442. 41 indexed citations
17.
Zhong, Zhen-Guo, et al.. (2005). [Protective effects of Panax notoginseng saponins against pathological lesion of cholinergic neuron in rat model with Alzheimer' s disease].. PubMed. 28(2). 119–22. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yong‐Zhan Zhen Breakdown of academic impact, for papers by Fangfang Li Breakdown of academic impact, for papers by Hui Chai Breakdown of academic impact, for papers by Xiufeng Ye Breakdown of academic impact, for papers by Asmaa Oun Breakdown of academic impact, for papers by Ayman A. Soubh Breakdown of academic impact, for papers by Min Sung Joo Breakdown of academic impact, for papers by Xia Yang Breakdown of academic impact, for papers by Zhuowei Gao
Rankless by CCL
2026